<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="87285">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01829451</url>
  </required_header>
  <id_info>
    <org_study_id>Uoulu</org_study_id>
    <nct_id>NCT01829451</nct_id>
  </id_info>
  <brief_title>Hyaluronic Acid Gel in Prevention of Intrauterine Adhesions After Endometrial Ablation</brief_title>
  <official_title>Autocrosslinked Hyaluronic Acid Gel in Prevention of Intrauterine Adhesions After Bipolar Radiofrequency Endometrial Ablation: a Randomised, Controlled and Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Oulu</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Oulu</source>
  <oversight_info>
    <authority>Finland: Ethics Committee</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the study is to evaluate if hyaluronic acid gel prevents intrauterine adhesion
      formation after endometrial thermal ablation.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">August 2012</completion_date>
  <primary_completion_date type="Actual">April 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>prevention of intrauterine adhesion formation</measure>
    <time_frame>3 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>The effect of hyaluronic acid gel on the formation of intrauterine adhesions after endometrial thermal ablation is assessed in an outpatient hysteroscopy after 3 months. Classification of intrauterine adhesions has been created for this study specifically.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">32</enrollment>
  <condition>Menorrhagia</condition>
  <arm_group>
    <arm_group_label>Hyaluronic acid gel</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Hyaluronic acid gel is placed into the uterus after endometrial ablation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No hyaluronic acid gel</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>An empty Pipelle device is taken into the uterus after endometrial ablation as an placebo procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Hyaluronic acid gel</intervention_name>
    <description>Hyaluronic acid gel is placed into the uterus after endometrial ablation
--------------------------------------------------------------------------------</description>
    <arm_group_label>Hyaluronic acid gel</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  menorrhagia

        Exclusion Criteria:

          -  abnormal uterine cavity,

          -  abnormal endometrial biopsy
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>52 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>April 2013</verification_date>
  <lastchanged_date>April 10, 2013</lastchanged_date>
  <firstreceived_date>March 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Menorrhagia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
